As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter. This information was brought to you by Cision http://news.cision.com https://news.cision.com/elekta/r/elekta-receives-initial-investment-grade-rating-from-s-p-global-ratings,c3440528 The following files are available for download: https://mb.cision.com/Main/35/3440528/1486502.pdf Sweden_New SP rating_2021_EN SOURCE Cision AB